RxDoctor Payments Data

Lea Pisching

Family · Fresno, CANPI 1568015121

Payments from drug & device makers

$15,442in general payments, 2019–2025

Across 818 payments — averaging $18.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Johnson & Johnson$2K
  • Incyte Corporation$1K
  • Sun Pharmaceutical Industries Inc.$1K
  • Novartis$896
  • LEO Pharma Inc.$866
  • plus $6K from 25 others

What the payments were for

  • Food & beverage$14,87596%
  • Education$5674%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,442 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
TremfyaGuselkumab12$159,188
Dupixent SyringeDupilumab14$51,031
Dupixent PenDupilumab13$48,330
Fluorouracil54$4,286
Clobetasol Propionate76$3,287
Ketoconazole99$1,539
Metronidazole27$1,237
Clindamycin Phosphate44$1,097
Triamcinolone Acetonide73$1,001
Hydroxychloroquine Sulfate12$730
Betamethasone Dipropionate22$635
Imiquimod21$451
Doxycycline Hyclate31$360
Gabapentin27$317
Hydrocortisone48$215

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonTremfya$1,818$159,18812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.

Other family in Fresno

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →